Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GMFG | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-10 |
mRNA | WAS | CTRPv2 | pan-cancer | AAC | 0.3 | 3e-06 |
mRNA | PARVG | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
mRNA | CECR6 | CTRPv2 | pan-cancer | AAC | 0.27 | 6e-15 |
mRNA | PTPN7 | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-08 |
mRNA | ARHGAP45 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-07 |
mRNA | ELAVL3 | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-09 |
mRNA | RASGRP2 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-09 |
mRNA | NCKAP1L | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-07 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-09 |